These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35217274)

  • 1. Trajectories of craving during medication-assisted treatment for opioid-use disorder: Subtyping for early identification of higher risk.
    Burgess-Hull AJ; Panlilio LV; Preston KL; Epstein DH
    Drug Alcohol Depend; 2022 Apr; 233():109362. PubMed ID: 35217274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal patterns of momentary stress during outpatient opioid agonist treatment: A growth-mixture-model approach to classifying patients.
    Burgess-Hull AJ; Smith KE; Schriefer D; Panlilio LV; Epstein DH; Preston KL
    Drug Alcohol Depend; 2021 Sep; 226():108884. PubMed ID: 34229153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stress, craving and mood as predictors of early dropout from opioid agonist therapy.
    Panlilio LV; Stull SW; Kowalczyk WJ; Phillips KA; Schroeder JR; Bertz JW; Vahabzadeh M; Lin JL; Mezghanni M; Nunes EV; Epstein DH; Preston KL
    Drug Alcohol Depend; 2019 Sep; 202():200-208. PubMed ID: 31357121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mindfulness-Oriented Recovery Enhancement reduces opioid craving among individuals with opioid use disorder and chronic pain in medication assisted treatment: Ecological momentary assessments from a stage 1 randomized controlled trial.
    Garland EL; Hanley AW; Kline A; Cooperman NA
    Drug Alcohol Depend; 2019 Oct; 203():61-65. PubMed ID: 31404850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond abstinence and relapse II: momentary relationships between stress, craving, and lapse within clusters of patients with similar patterns of drug use.
    Panlilio LV; Stull SW; Bertz JW; Burgess-Hull AJ; Lanza ST; Curtis BL; Phillips KA; Epstein DH; Preston KL
    Psychopharmacology (Berl); 2021 Jun; 238(6):1513-1529. PubMed ID: 33558983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using ecological momentary assessment to examine the relationship between craving and affect with opioid use in a clinical trial of clonidine as an adjunct medication to buprenorphine treatment.
    Kowalczyk WJ; Moran LM; Bertz JW; Phillips KA; Ghitza UE; Vahabzadeh M; Lin JL; Epstein DH; Preston KL
    Am J Drug Alcohol Abuse; 2018; 44(5):502-511. PubMed ID: 29634425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in daily life stress and craving in opioid-dependent patients.
    Moran LM; Kowalczyk WJ; Phillips KA; Vahabzadeh M; Lin JL; Mezghanni M; Epstein DH; Preston KL
    Am J Drug Alcohol Abuse; 2018; 44(5):512-523. PubMed ID: 29641291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Before and after: craving, mood, and background stress in the hours surrounding drug use and stressful events in patients with opioid-use disorder.
    Preston KL; Kowalczyk WJ; Phillips KA; Jobes ML; Vahabzadeh M; Lin JL; Mezghanni M; Epstein DH
    Psychopharmacology (Berl); 2018 Sep; 235(9):2713-2723. PubMed ID: 29980821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Context and craving during stressful events in the daily lives of drug-dependent patients.
    Preston KL; Kowalczyk WJ; Phillips KA; Jobes ML; Vahabzadeh M; Lin JL; Mezghanni M; Epstein DH
    Psychopharmacology (Berl); 2017 Sep; 234(17):2631-2642. PubMed ID: 28593441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-individual variability and stability of affect and craving among individuals receiving medication treatment for opioid use disorder.
    Ellis JD; Mun CJ; Epstein DH; Phillips KA; Finan PH; Preston KL
    Neuropsychopharmacology; 2022 Sep; 47(10):1836-1843. PubMed ID: 35668168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exacerbated Craving in the Presence of Stress and Drug Cues in Drug-Dependent Patients.
    Preston KL; Kowalczyk WJ; Phillips KA; Jobes ML; Vahabzadeh M; Lin JL; Mezghanni M; Epstein DH
    Neuropsychopharmacology; 2018 Mar; 43(4):859-867. PubMed ID: 29105663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonidine Maintenance Prolongs Opioid Abstinence and Decouples Stress From Craving in Daily Life: A Randomized Controlled Trial With Ecological Momentary Assessment.
    Kowalczyk WJ; Phillips KA; Jobes ML; Kennedy AP; Ghitza UE; Agage DA; Schmittner JP; Epstein DH; Preston KL
    Am J Psychiatry; 2015 Aug; 172(8):760-7. PubMed ID: 25783757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heroin anticraving medications: a systematic review.
    Fareed A; Vayalapalli S; Casarella J; Amar R; Drexler K
    Am J Drug Alcohol Abuse; 2010 Nov; 36(6):332-41. PubMed ID: 20955107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prefrontal cortex response to drug cues, craving, and current depressive symptoms are associated with treatment outcomes in methadone-maintained patients.
    Huhn AS; Sweeney MM; Brooner RK; Kidorf MS; Tompkins DA; Ayaz H; Dunn KE
    Neuropsychopharmacology; 2019 Mar; 44(4):826-833. PubMed ID: 30375498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in cocaine/heroin users: drug-use triggers and craving in daily life.
    Kennedy AP; Epstein DH; Phillips KA; Preston KL
    Drug Alcohol Depend; 2013 Sep; 132(1-2):29-37. PubMed ID: 23357742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between cannabis use and patient outcomes in medication-based treatment of opioid use disorder: A systematic review.
    Lake S; St Pierre M
    Clin Psychol Rev; 2020 Dec; 82():101939. PubMed ID: 33130527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining differences in retention on medication for opioid use disorder: An analysis of Ohio Medicaid data.
    Zhang P; Tossone K; Ashmead R; Bickert T; Bailey E; Doogan NJ; Mack A; Schmidt S; Bonny AE
    J Subst Abuse Treat; 2022 May; 136():108686. PubMed ID: 34953637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prior use of medications for opioid use disorder in ED patients with opioid overdose: prevalence, misuse and overdose severity.
    Shastry S; Nobel I; Allen LR; Richardson LD; Vidal K; Manini AF
    Am J Emerg Med; 2022 Jan; 51():114-118. PubMed ID: 34735968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impulsivity and craving in subjects with opioid use disorder on methadone maintenance treatment.
    Li J; Weidacker K; Mandali A; Zhang Y; Whiteford S; Ren Q; Zhou Z; Zhou H; Jiang H; Du J; Zhang C; Sun B; Voon V
    Drug Alcohol Depend; 2021 Feb; 219():108483. PubMed ID: 33385690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Craving mediates the association between momentary pain and illicit opioid use during treatment for opioid-use disorder: an ecological momentary assessment study.
    Mun CJ; Finan PH; Epstein DH; Kowalczyk WJ; Agage D; Letzen JE; Phillips KA; Preston KL
    Addiction; 2021 Jul; 116(7):1794-1804. PubMed ID: 33220102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.